Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cossac L in vasomotor rhinitis
NCT01509209Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- May 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levocetirizine, pseudoephedrine in vasomotor rhinitis (VMR), sponsored by Hanmi Pharmaceutical. Started May 2011; status: completed.
02
Drugs
levocetirizinepseudoephedrine
03
Conditions
vasomotor rhinitis (VMR)
Beyond the preview
Go deeper on NCT01509209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01509209.